What Can Drive A 15% Downside To CME’s Stock In The Next 2 Years?
There could be almost a 15% downside to our price estimate for CME in the next few years if the rate per contract for financial derivatives grows at a slower than expected pace, owing to the increasing competition in the financial markets. This in turn may negatively affect revenues from financial derivatives. The table below shows what would drive the downside.
Have more questions about CME? See the links below:
- CME Group Sees Growth In All Asset Classes In February
- What’s CME’s Revenue And EBITDA Breakdown In Terms Of Operating Segments?
- How Has CME’s Revenue Composition Changed Over The Past 5 Years?
- How Has CME’s Revenue & EBITDA Changed In The Last Five Years?
- How Is CME Expected To Grow In The Next Five Years?
- What Is CME’s Fundamental Value Based On Expected 2016 Results?
- What Drove CME’s Revenue And EBITDA Growth In 2015?
- How Important Is Interest Rate Contracts’ Trading Revenue For CME?
- What Percentage Of CME’s Value Comes From Energy Contracts’ Trading Revenues?
- How Much Upside Can An Increase In Rate Per Commodity Contract Drive For CME’s Stock?
Notes:
View Interactive Institutional Research (Powered by Trefis):
Global Large Cap | U.S. Mid & Small Cap | European Large & Mid Cap
More Trefis Research